Dr. Roy E. Weiss, MD

Dr. Weiss practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Weiss' NPI, 1104989623, was assigned on December 18, 2006. Dr. Weiss graduated from Tel Aviv University Sackler in 1985. Dr. Weiss holds Florida license ME119448.

Dr. Weiss' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Weiss' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Weiss to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weiss practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Weiss' primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Weiss is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Weiss' licenses on file in 4 states: Florida, New York, Illinois and Missouri.

Dmand AI lists chronic diabetes, enlarged thyroid, hypercalcemia, osteoporosis, overactive thyroid and underactive thyroid among the conditions Dr. Weiss treats.

CMS data shows 46 Medicare services from Dr. Weiss across 2 procedure codes in 2024, all of them office visits, for 50 Medicare patients. Medicare paid $5,361 for them. Every service was in an office.

CMS counts 50 Medicare patients who saw Dr. Weiss in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weiss' median patient age at 58, with 63% women.

In 2024, Dr. Weiss wrote 277 Medicare Part D claims for 50 patients. 43% of them were for generic drugs. CMS names the drug for 216 of them, across 6 drugs with 11 or more claims each, at $86,160 in total drug cost. In 2023, CMS named 159 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Weiss for performance year 2024, reported as part of a group. Dr. Weiss accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weiss as offering telehealth.

Dmand AI links 267 papers to Dr. Weiss, published from 2001 to 2024. 2014 was the busiest year, with 7. The most frequent topics are Thyroid Hormones, Thyrotropin and Thyroxine. Dr. Weiss has published most often in J Clin Endocrinol Metab. Dr. Weiss' most frequent co-authors are Samuel Refetoff, MD, Zeina C. Hannoush, MD and Mark Allen Stein, MD.

Dmand AI links Dr. Weiss to 1 clinical trial. Conditions studied include Allan-Herndon-Dudley syndrome.

CMS Open Payments shows 2 general payments to Dr. Weiss from 2 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $143.

Dmand AI lists 7 awards for Dr. Weiss, most recently America's Top Doctors in 2014.

Dr. Weiss graduated from Tel Aviv University Sackler in 1985. Dr. Weiss is a member of ACP.

Dr. Weiss is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.